In this episode of Deep Tech Talk, hosts Chris and Sarah dive into the evolving landscape of Hunter Syndrome (MPS II)—a rare genetic disorder that’s inspiring breakthroughs in gene therapy and brain-targeted treatments. Drawing insights from BIS Research, they explore how innovation is reshaping diagnosis, treatment, and patient outcomes. From enzyme replacement therapy challenges to emerging CNS-focused solutions and upcoming FDA decisions, this episode unpacks the market forces and scientific progress driving change.

🎧 Tune in to discover how next-generation therapies could transform the future of rare-disease care.

#DeepTechTalk #HunterSyndrome #BISResearch #RareDisease